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combined endpoint events the Group D, E increased signiﬁcantly. OR values were
1.451 and 1.902.
Conclusions: Admission white blood cell count was an independent risk factor for
short-term outcome in primary PCI with STEMI patients.
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Objectives: Despite advances in the management of patients with acute myocardial
infarction, a variety of complications and death remain high during hospitalization of
acute myocardial infarction. Therefore, it is important that the risk factors of 30-day
mortality in patients with acute myocardial infarction are explored for improving the
outcomes of acute myocardial infarction.
Methods: All hospital admissions with a discharge diagnosis of acute myocardial
infarction were extracted from the Chinese PLA General Hospital Patients Infor-
mation System Database from the January 1st in 2011 to the December 31st 2012.
Cox’s regression on mortality was performed using SPSS19 statistical software for
the age, the sex, the history of diabetes, myocardial infarction, aerial ﬁbrillation,
stroke, chronic renal failure, anemia, or coronary artery bypass graft, the compli-
cation of cardiogenic shock, heart failure, ventricular ﬁbrillation/ventricular tachy-
cardia, atrioventricular block II, III degree, acute renal failure, gastrointestinal
hemorrhage, or multiple organ dysfunction syndrome and the percutenous coronary
intervention.
Results: Of 1869 cases, 91 (4.9%) patients (mean age 74.3  10.9 years old) died.
Among the patients, 1342 cases were male, and 437 cases female, mean age 61.1 
13.4 years old.. Univariate analysis showed age, sex, the history of diabetes,
myocardial infarction, aerial ﬁbrillation, stroke, chronic renal failure, anemia, or
coronary artery bypass graft, complication of cardiogenic shock, heart failure, ven-
tricular ﬁbrillation/ventricular tachycardia, atrioventricular block II, III degree, acute
renal failure, gastrointestinal hemorrhage, or multiple organ dysfunction syndrome
and percutenous coronary intervention were predictive factors of 30 day mortality.
Cox regression analysis indicated that the independent predictive factors of the 30 day
mortality rate were the age (odds ratio [OR] 1.065, 95% conﬁdence interval [CI]
1.042-1.089), the history of diabetes (OR 1.858, CI 1.190-2.901), or anemia (OR
2.893, CI 1.483-5.642), the complication of cardiogenic shock (OR 12.596, CI 7.454-
21.193), ventricular ﬁbrillation/ventricular tachycardia (OR 8.904, CI 4.000-19.821),
acute renal failure (OR 3.753, CI 1 814-7.765), or multiple organ dysfunction
syndrome (OR 4.060, CI 1.586-10.396), and the percutenous coronary intervention
(OR 0.345, CI 0.204-0.583).
Conclusions: The age, the history of diabetes, anemia, the complication of cardio-
genic shock, ventricular ﬁbrillation/ventricular tachycardia, acute renal failure, mul-
tiple organ dysfunction syndrome and the percutenous coronary intervention are
independent predictive factors of 30 days mortality in patients with acute myocardial
infarction.
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Objectives: The development of microvascular reperfusion injury is associated with
adverse clinical outcomes in patients with ST-elevation myocardial infarction
(STEMI) undergoing primary percutaneous coronary intervention (PCI). Upfront
strategies to reduce the incidence of microvascular reperfusion injury could be
considered for high-risk patients to improve outcomes. To examine the role of
intracoronary anisodamine and diltiazem administration performed before stenting on
the immediate angiographic and clinical outcomes.
Methods: STEMI patients with high-risk of no reﬂow presenting with primary PCI
were randomized to 2 bolus injections of intracoronary anisodamine (1mg/5mL)
and diltiazem (2mg/5mL) or diltiazem (2mg/5mL). The ﬁrst bolus injection was
given after guidewire and the second after the ﬁrst balloon inﬂation. The primary
endpoint was the incidence of no/slow reﬂow (TIMI ﬂow grade2) immediately
after stenting.
Results: A total of 108 patients were randomized to intracoronary anisodamine and
diltiazem (COM group, n¼54) or diltiazem (Diltiazem group, n¼54). The percents of
TIMI ﬂow grade 3 was found higher in the COM group than in the Diltiazem group
(92.6% vs 75.9%, p<0.05). TMPG 3 was obtained more frequently in the COM group
than in the Diltiazem group (68.5% vs 46.3%, p<0.05). cTFC was signiﬁcantly lower
in the COM group than in the Diltiazem group (30 vs 44, p<0.05). COM group had
showed low incidences of bradyarrhythmia and rapid arrhythmia (7.4% vs 24.1% and
3.7% vs 18.5%, respectively, p<0.05).
Conclusions: Intracoronary anisodamine and diltiazem administration before stenting
improved the angiographic results and prevented reperfusion arrhythmia in patients
with STEMI undergoing PCI.C130 JACC Vol 64/16/Suppl C j October 16–1GW25-e4324
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Objectives: To screen differential microRNA expression proﬁles of CD4+T
lymphocyte from the patients with acute coronary sysdrome (ACS) and the healthy
controls by microarray analysis technique. To elucidate the mechanism responsible for
modulation of CD4+T lymphocyte and provide insights into the effects of microRNA
on ACS.
Methods: Ten patients with ACS were enrolled in the study, and ten patients with
normal coronary artery angiogram were served as a control group. Blood samples
were taken from peripheral vein and the CD4+T lymphocytes were isolated from
mononuclear cells prepared with Ficoll-Hypaque density-gradients centrifugation
from human peripheral blood by magnetic cell sorting system (MACS). The purity of
CD4+T lymphocytes was measured by ﬂow cytometry analysis. The viable count was
detected by the rejection experiment of trypanblau. Total RNA was abstracted from
CD4+T lymphocyte with Trizol reagent. McroiRNA was isolated and enriched of by
use of Polyethylene Glycol from 40mg total RNA.The microRNA extracted from
CD4+T lymphocytes was hybridized and microRNA expressions proﬁles of CD4+T
lymphocyte were screened with the Affymetrix GeneChip microRNA array. The
image signal was scanned by Affymetrix GeneChip Scanner 3000 and analysised by
Affymetrix GeneChip Command ConsoleTM 1.1 software. Then the image signal was
transformed into digital information, which was analysised with SAM software. The
differentially expressed microRNA were identiﬁed between the two groups. Real-time
quantitative polymerase chain reaction (qRT-PCR) was used to conﬁrm the result of
selected genes from microarray analysis.
Results: The results showed that the expression of mcroiRNA-155, microRNA-21,
microRNA-424 and microRNA-127-3p were over 1.5 folds up-regulated, and the
expression of microRNA-30b and microRNA-181a were over 0.5 folds down-regu-
lated in ACS group compared to the control group. The qRT-PCR results were in
accordance with those obtained using microarray analysis.
Conclusions: The differentially expressed microRNA of CD4+T lymphocyte may
participate in the the occuring and developing of ACS.
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Objectives: Red Blood Cell Distribution Width (RDW) is an indicator which can
react the degree of the dispersion of outer peripheral red blood cell volume. Recently,
studies have shown that the baseline of RDW is closely related with various heart
diseases. This study aimed to explore the changes of RDW in acute coronary syn-
drome (ACS), and to analyze the relation of RDW with the severity of coronary artery
disease and long-term (two-year ) prognosis.
Methods: A total of 218 patients (aged 27-85 years, 54.59% men) were enrolled in
this study, including 140 patients with ACS and 78 patients without ACS. The group
of ACS contained 60 patients with STEMI and 26 patients with NSTEMI and 54
patients with UA. All the patients had coronary arteriography (CAG), then Gensini
score was calculated. All detailed records of general condition and results of the
routine examinations were recorded. Every ACS patient had an interview by phone
after two years to evaluate adverse cardiovascular events during the two years, such as
angina pectorals grade of CCS raised at least of 1 grade, onset of heart failure,
recurrencerecurrence of myocardial infarction, cardiac death. According to the
thresholds of RDW determined by ROC curve analysis, ACS patients were divided
into high-levels group and low-levels group, the incidence of long-term adverse
cardiovascular events between the two groups was compared.
Results: (1) The average level of RDW was signiﬁcantly higher in ACS group than
it in control group [(12.810.55) % vs (12.280.41) %, P<0.001]. ACS patients
with myocardial infarction had higher level of RDW than those without myocardial
infarction [(12.920.57) % vs (12.630.46) %, P¼0.001].(2) Spearman correlation
analysis showed that RDW was positively associated with Gensini score signiﬁ-
cantly (r¼0.463, P<0.001), and also positive linear correlated with coronary artery
lesions (r¼0.295, P <0.001).(3) ROC curve analysis showed that test performance
was the best when RDW was 12.85%[area under curve¼0.87, P<0.01]. There were
57 cases of adverse cardiovascular events during the two-year follow-up periods.
Compared with low-levels group (RDW<12.85%), the incidence of long-term
cardiovascular events of high-levels group (RDW12.85%) increased signiﬁcantly
(56.72% vs 26.03%, P<0.001). Logistic regression analysis showed that NT-
proBNP (P¼0.007), LDL-C (P¼0.038), apolipoprotein-B (P¼0.030) and RDW
(P¼0.010) were the predictors of long-term adverse cardiovascular events.
(4) Spearman correlation analysis also showed that RDW was positively correlated
with WBC, AST, LDH, cTnI, hs-CRP, NT-proBNP and LVED, while it was
negatively relative with LVEF and MCV. Multiple stepwise regression analysis
showed that RDW was positively correlated with WBC (r¼0.232, P<0.001) and
hs-CRP (r¼0.352, P<0.001), while negatively correlated with LVEF (r¼-0.213,
P<0.001).
Conclusions: (1) The level of RDW in patients with ACS increased signiﬁcantly, and
ACS patients with AMI had higher level of RDW compared with those without AMI.9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
